当前位置: X-MOL 学术Chem. Data Collect. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Synthesis, anticancer evaluation and molecular docking studies of 1,3,4-Oxadiazole linked Resveratrol derivatives
Chemical Data Collections Pub Date : 2020-12-01 , DOI: 10.1016/j.cdc.2020.100570
Venakata Naresh Vema , Bharathi Kumari Y , Venkata Basaveswara Rao Mandava , Sridhar Mussulla , Ramakrishnam Raju Addada , Srinivasa Rao A

Abstract A new series of 1,3,4-Oxadiazole linked Resveratrol (9a-j) have been synthesized and characterized by 1HNMR, 13CNMR, ESI-MS spectral analysis. The in vitro cytotoxicity effects of synthesized compounds were evaluated against four different human cancer cells including MCF-7, MDA MB-231 (Breast) and A549 (Lung) cell lines. The biological results showed that most of the compounds significantly prevented the proliferation of tested cancer cells.In particular, compound 9b and 9j showed potent anticancer activities against MCF-7 (IC50 = 1.56, 0.45 µM, respectively), A549 (IC50 = 0.11, 1.11 µM, respectively) MDA-MB-231 (IC50 = 1.22, 1.98 µM, respectively). Molecular docking studies revealed that compound 9b selectively occupy the colchicine binding site of the tubulin polymer.

中文翻译:

1,3,4-恶二唑连接的白藜芦醇衍生物的合成、抗癌评价和分子对接研究

摘要 合成了一个新系列的1,3,4-恶二唑连接的白藜芦醇(9a-j),并通过1HNMR、13CNMR、ESI-MS 光谱分析对其进行了表征。针对四种不同的人类癌细胞,包括 MCF-7、MDA MB-231(乳房)和 A549(肺)细胞系,评估了合成化合物的体外细胞毒性作用。生物学结果表明,大多数化合物显着阻止了受试癌细胞的增殖。特别是化合物 9b 和 9j 对 MCF-7(IC50 分别为 1.56、0.45 µM)、A549(IC50 = 0.11,分别为 1.11 µM)MDA-MB-231(分别为 IC50 = 1.22、1.98 µM)。分子对接研究表明,化合物 9b 选择性地占据了微管蛋白聚合物的秋水仙碱结合位点。
更新日期:2020-12-01
down
wechat
bug